Lisa Wilson
Psychiatric/Mental Health · Fort Myers, FLNPI 1124502018
Payments from drug & device makers
Across 144 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$650
- Alkermes, Inc.$242
- Otsuka America Pharmaceutical, Inc.$237
- Tempus AI, Inc$186
- Johnson & Johnson$168
- Corium, LLC$120
- plus $978 from 22 others
What the payments were for
- Food & beverage$2,581100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,581 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 26 | $210,007 |
| VraylarCariprazine Hcl | 116 | $160,444 |
| LybalviOlanzapine/Samidorphan Malate | 15 | $24,772 |
| TrintellixVortioxetine Hydrobromide | 18 | $18,488 |
| Aripiprazole | 130 | $6,624 |
| BelsomraSuvorexant | 16 | $6,316 |
| Ramelteon | 36 | $6,041 |
| Atomoxetine Hcl | 22 | $4,660 |
| Duloxetine Hcl | 203 | $4,589 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 40 | $4,080 |
| Bupropion XlBupropion Hcl | 143 | $3,861 |
| Buspirone Hcl | 202 | $3,431 |
| Quetiapine Fumarate | 243 | $3,363 |
| Clonazepam | 314 | $2,590 |
| Trazodone Hcl | 227 | $2,538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $56 | $210,00726 claims |
| AbbVieVraylar | $650 | $160,444116 claims |
| Alkermes, Inc.Lybalvi | $242 | $24,77215 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $109 | $18,48818 claims |
| Lilly USA, LLCOlanzapine | $51 | $1,38156 claims |
| Almatica Pharma LLCSertraline Hcl | $32 | $81696 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Fort Myers
- Dylan DemarsFort Myers$24K
- Jacqueline BannisterFort Myers$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.